Active suppression of tumor-specific T lymphocytes can limit the efficacy of immune surveillance and immunotherapy. While tumor-recruited CD11b+ myeloid cells are known mediators of tumor-associated immune dysfunction, the true nature of these suppressive cells and the fine biochemical pathways governing their immunosuppressive activity remain elusive. Here we describe a population of circulating CD11b+IL-4 receptor α+ (CD11b+IL-4Rα+), inflammatory-type monocytes that is elicited by growing tumors and activated by IFN-γ released from T lymphocytes. CD11b+IL-4Rα+ cells produced IL-13 and IFN-γ and integrated the downstream signals of these cytokines to trigger the molecular pathways suppressing antigen-activated CD8+ T lymphocytes. Analogous immunosuppressive circuits were active in CD11b+ cells present within the tumor microenvironment. These suppressor cells challenge the current idea that tumor-conditioned immunosuppressive monocytes/macrophages are alternatively activated. Moreover, our data show how the inflammatory response elicited by tumors had detrimental effects on the adaptive immune system and suggest novel approaches for the treatment of tumor-induced immune dysfunctions.
Giovanna Gallina, Luigi Dolcetti, Paolo Serafini, Carmela De Santo, Ilaria Marigo, Mario P. Colombo, Giuseppe Basso, Frank Brombacher, Ivan Borrello, Paola Zanovello, Silvio Bicciato, Vincenzo Bronte
Title and authors | Publication | Year |
---|---|---|
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3
R Trovato, A Fiore, S Sartori, S Canè, R Giugno, L Cascione, S Paiella, R Salvia, FD Sanctis, O Poffe, C Anselmi, F Hofer, S Sartoris, G Piro, C Carbone, V Corbo, R Lawlor, S Solito, L Pinton, S Mandruzzato, C Bassi, A Scarpa, V Bronte, S Ugel |
Journal for ImmunoTherapy of Cancer | 2019 |
Myeloid-Derived Suppressor Cells Promote Metastasis in Breast Cancer After the Stress of Operative Removal of the Primary Cancer
X Ma, M Wang, T Yin, Y Zhao, X Wei |
Frontiers in Oncology | 2019 |
CCR2 Chemokine Receptors Enhance Growth and Cell-Cycle Progression of Breast Cancer Cells through SRC and PKC Activation
M Yao, W Fang, C Smart, Q Hu, S Huang, N Alvarez, P Fields, N Cheng |
Molecular cancer research : MCR | 2019 |
Synergetic Functional Nanocomposites Enhance Immunotherapy in Solid Tumors by Remodeling the Immunoenvironment
L Yang, J Sun, Q Liu, R Zhu, Q Yang, J Hua, L Zheng, K Li, S Wang, A Li |
Advanced Science | 2019 |
Myeloid Cell Crosstalk Regulates the Efficacy of the DNA/ALVAC/gp120 HIV Vaccine Candidate
M Vaccari, S Fourati, DR Brown, IS de Castro, M Bissa, L Schifanella, MN Doster, KE Foulds, M Roederer, RA Koup, Y Sui, JA Berzofsky, RP Sekaly, G Franchini |
Frontiers in immunology | 2019 |
Candida/Staphylococcal Polymicrobial Intra-Abdominal Infection: Pathogenesis and Perspectives for a Novel Form of Trained Innate Immunity
SK Esher, PL Fidel, MC Noverr |
Journal of Fungi | 2019 |
Sculpting tumor microenvironment with immune system: from immunometabolism to immunoediting
YR Yu, PC Ho |
Clinical & Experimental Immunology | 2019 |
Dissecting intratumoral myeloid cell plasticity by single cell RNA‐seq
Q Song, GA Hawkins, L Wudel, PC Chou, E Forbes, AK Pullikuth, L Liu, G Jin, L Craddock, U Topaloglu, G Kucera, S ONeill, EA Levine, P Sun, K Watabe, Y Lu, MA AlexanderMiller, B Pasche, LD Miller, W Zhang |
Cancer Medicine | 2019 |
Autologous Hematopoietic Stem Cells Are a Preferred Source to Generate Dendritic Cells for Immunotherapy in Multiple Myeloma Patients
P Shinde, S Melinkeri, MK Santra, V Kale, L Limaye |
Frontiers in immunology | 2019 |
Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer
A Jayakumar, AL Bothwell |
Journal of immunology (Baltimore, Md. : 1950) | 2019 |
CCR5 status and metastatic progression in colorectal cancer
M Suarez-Carmona, P Chaorentong, JN Kather, R Rothenheber, A Ahmed, A Berthel, A Heinzelmann, R Moraleda, NA Valous, Z Kosaloglu, R Eurich, J Wolf, S Grauling-Halama, M Hundemer, F Lasitschka, F Klupp, C Kahlert, A Ulrich, M Schneider, C Falk, D Jäger, I Zoernig, N Halama |
OncoImmunology | 2019 |
Immuno-subtyping of breast cancer reveals distinct myeloid cell profiles and immunotherapy resistance mechanisms
IS Kim, Y Gao, T Welte, H Wang, J Liu, M Janghorban, K Sheng, Y Niu, A Goldstein, N Zhao, I Bado, HC Lo, MJ Toneff, T Nguyen, W Bu, W Jiang, J Arnold, F Gu, J He, D Jebakumar, K Walker, Y Li, Q Mo, TF Westbrook, C Zong, A Rao, A Sreekumar, JM Rosen, XH Zhang |
Nature Cell Biology | 2019 |
Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite
KJ Filbey, F Varyani, Y Harcus, JP Hewitson, DJ Smyth, HJ McSorley, A Ivens, S Nylén, M Rottenberg, S Löser, RM Maizels |
Frontiers in immunology | 2019 |
Sustained Delivery of Carfilzomib by Tannic Acid-Based Nanocapsules Helps Develop Antitumor Immunity
MS Taha, GM Cresswell, J Park, W Lee, TL Ratliff, Y Yeo |
Nano letters | 2019 |
Lactoferrin deficiency induces a pro-metastatic tumor microenvironment through recruiting myeloid-derived suppressor cells in mice
L Wei, X Zhang, J Wang, Q Ye, X Zheng, Q Peng, Y Zheng, P Liu, X Zhang, Z Li, C Liu, Q Yan, G Li, J Ma |
Oncogene | 2019 |